{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", docket_id = \"FDA-2019-N-5959\" and posted_year = 2023 sorted by posted_date descending", "rows": [["FDA-2019-N-5959-0101", "FDA", "FDA-2019-N-5959", "Reference 48 - Preliminary Regulatory Impact Analysis--Initial Regulatory Flexibility Analysis and Unfunded Mandates Reform Act Analysis for Medication Guides--PMI RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-16T04:00:00Z", 2023, 6, null, null, "2023-06-16T18:21:16Z", null, 0, 0, "0900006485adf12f"], ["FDA-2019-N-5959-0051", "FDA", "FDA-2019-N-5959", "Reference 49 - Consumers Better Understand and Prefer Simplified Written Drug Information: An Evaluation of 2 Novel Formats Versus the Current CMI - 2013 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:31:07Z", null, 0, 0, "0900006485a969fe"], ["FDA-2019-N-5959-0053", "FDA", "FDA-2019-N-5959", "Reference 51 - Medication adherence: A call for action - 2011 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:31:36Z", null, 0, 0, "0900006485a969ff"], ["FDA-2019-N-5959-0032", "FDA", "FDA-2019-N-5959", "Reference 29 - Exploring the Promise of Patient Medication Information July 1, 2014 - Meeting Summary RE Medication Guides: Patient Medication\nInformation", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:27:03Z", null, 0, 0, "0900006485a94a2d"], ["FDA-2019-N-5959-0033", "FDA", "FDA-2019-N-5959", "Reference 30 - FDA Public Hearing - Development and Distribution of Patient Medication Information for Prescription Drugs - 2010 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:26:24Z", null, 0, 0, "0900006485a94a2e"], ["FDA-2019-N-5959-0041", "FDA", "FDA-2019-N-5959", "Reference 38 - Usability of FDA-Approved Medication Guides - 2012 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:28:59Z", null, 0, 0, "0900006485a94a34"], ["FDA-2019-N-5959-0044", "FDA", "FDA-2019-N-5959", "Reference 41 - Designing Instructional and Informational Text - 2004 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:29:38Z", null, 0, 0, "0900006485a94c31"], ["FDA-2019-N-5959-0020", "FDA", "FDA-2019-N-5959", "Reference 17 - FDA Minutes of the Risk Communication Advisory Committee -February 26-27, 2009 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:05:13Z", null, 0, 0, "0900006485a94951"], ["FDA-2019-N-5959-0012", "FDA", "FDA-2019-N-5959", "Reference 09 - Steering Committee for the Collaborative Development of a Long- Range Action Plan for the Provision of Useful Prescription Medicine Information - 1996 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:01:58Z", null, 0, 0, "0900006485a9479d"], ["FDA-2019-N-5959-0057", "FDA", "FDA-2019-N-5959", "Reference 55 - Willingness to pay to standardize patient medication information - 2021 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:33:02Z", null, 0, 0, "0900006485a970f0"], ["FDA-2019-N-5959-0070", "FDA", "FDA-2019-N-5959", "Reference 68 - Experimental Study of Patient Information Prototypes RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:36:58Z", null, 0, 0, "0900006485a99169"], ["FDA-2019-N-5959-0072", "FDA", "FDA-2019-N-5959", "Reference 70 - Preferences for Patient Medication Information: What Do Patients Want? RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:37:22Z", null, 0, 0, "0900006485a991be"], ["FDA-2019-N-5959-0048", "FDA", "FDA-2019-N-5959", "Reference 45 - Effects of Headings on Text Summarization - 2001 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:30:26Z", null, 0, 0, "0900006485a94c33"], ["FDA-2019-N-5959-0069", "FDA", "FDA-2019-N-5959", "Reference 67 - IQVIA 2019 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:36:44Z", null, 0, 0, "0900006485a99168"], ["FDA-2019-N-5959-0023", "FDA", "FDA-2019-N-5959", "Reference 20 - FDA - Prototype 2 Rheutopia - 2009 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:08:14Z", null, 0, 0, "0900006485a94952"], ["FDA-2019-N-5959-0005", "FDA", "FDA-2019-N-5959", "Reference 02 - Medication Adherence Measures: An Overview - 2015 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T17:59:10Z", null, 0, 0, "0900006485a94798"], ["FDA-2019-N-5959-0030", "FDA", "FDA-2019-N-5959", "Reference 27 - Designing Pilot Programs to Distribute Patient Medication Information - 2011 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:14:23Z", null, 0, 0, "0900006485a94957"], ["FDA-2019-N-5959-0011", "FDA", "FDA-2019-N-5959", "Reference 08 - USPHS Healthy People 2000: National Health Promotion and Disease Prevention Objectives and Full Report, with Commentary - 1991 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:01:43Z", null, 0, 0, "0900006485a9479c"], ["FDA-2019-N-5959-0050", "FDA", "FDA-2019-N-5959", "Reference 47 - Consumer Understanding and Use of Nutrition Labelling: A Systematic Review - 2004 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:30:54Z", null, 0, 0, "0900006485a94c35"], ["FDA-2019-N-5959-0068", "FDA", "FDA-2019-N-5959", "Reference 66 - IQVIA 2018 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:36:27Z", null, 0, 0, "0900006485a98d69"], ["FDA-2019-N-5959-0073", "FDA", "FDA-2019-N-5959", "Reference 71 - 2014 FDA Labeling Cost Model RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:37:35Z", null, 0, 0, "0900006485a99647"], ["FDA-2019-N-5959-0078", "FDA", "FDA-2019-N-5959", "Reference 76 - U.S. Census 2015_SUSB data by employment size RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:38:37Z", null, 0, 0, "0900006485a996e4"], ["FDA-2019-N-5959-0039", "FDA", "FDA-2019-N-5959", "Reference 36 - Written Medicines Information for South African HIV-AIDS Patients: Does It Enhance Understanding of Co-Trimoxazole Therapy? - 2007 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:28:34Z", null, 0, 0, "0900006485a94a33"], ["FDA-2019-N-5959-0045", "FDA", "FDA-2019-N-5959", "Reference 42 - Interpretation of Medication Pictograms by Adults in the UK - 2005 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:29:48Z", null, 0, 0, "0900006485a94bd7"], ["FDA-2019-N-5959-0049", "FDA", "FDA-2019-N-5959", "Reference 46 - The Effects of Headings in Information Mapping on Search Speed and Evaluation of a Brief Health Education Text - 2007 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:30:41Z", null, 0, 0, "0900006485a94c34"], ["FDA-2019-N-5959-0028", "FDA", "FDA-2019-N-5959", "Reference 25 - Expert Workshop: The Science of Communicating Medication Information to Consumers - 2010 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:04:08Z", null, 0, 0, "0900006485a94955"], ["FDA-2019-N-5959-0018", "FDA", "FDA-2019-N-5959", "Reference 15 - National Association of Chain Drug Stores - Citizen Petition Requesting FDA Action on a \"One Document Solution\" for All Pharmacy-Based Communications - 2008 - Docket FDA-2008-P-0380 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:03:50Z", null, 0, 0, "0900006485a8e581"], ["FDA-2019-N-5959-0021", "FDA", "FDA-2019-N-5959", "Reference 18 - FDA - Providing Effective Information to Consumers About Prescription Drug Risks and Benefits - The Issues Paper - Background Paper - 2009 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:07:20Z", null, 0, 0, "0900006485a8e582"], ["FDA-2019-N-5959-0075", "FDA", "FDA-2019-N-5959", "Reference 73 - Drug Therapy Adherence to Medication RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:38:01Z", null, 0, 0, "0900006485a991c5"], ["FDA-2019-N-5959-0029", "FDA", "FDA-2019-N-5959", "Reference 26 - Ensuring Access to Effective Patient Medication Information - 2010 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:04:20Z", null, 0, 0, "0900006485a94956"], ["FDA-2019-N-5959-0061", "FDA", "FDA-2019-N-5959", "Reference 59 - Unique Device Identification System; Final Rule RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:33:52Z", null, 0, 0, "0900006485a9871a"], ["FDA-2019-N-5959-0038", "FDA", "FDA-2019-N-5959", "Reference 35 - Patients Use and Perception of Medication Information Leaflets - 2007 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:28:17Z", null, 0, 0, "0900006485a94a32"], ["FDA-2019-N-5959-0047", "FDA", "FDA-2019-N-5959", "Reference 44 - Prescription Painkillers and Controlled Substances: An Appraisal of Drug Information Provided by Six US Pharmacies - 2013 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:30:12Z", null, 0, 0, "0900006485a94c32"], ["FDA-2019-N-5959-0055", "FDA", "FDA-2019-N-5959", "Reference 53 - May 2020 National Industry-Specific Occupational Employment and Wage Estimates NAICS 325400 - Pharmaceutical and Medicine Manufacturing RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:32:37Z", null, 0, 0, "0900006485a96b84"], ["FDA-2019-N-5959-0037", "FDA", "FDA-2019-N-5959", "Reference 34 - Consumers Better Understand and Prefer Simplified Written Drug Information--An Evaluation of 2 Novel Formats Versus the Current CMI - 2013 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:28:04Z", null, 0, 0, "0900006485a9495a"], ["FDA-2019-N-5959-0035", "FDA", "FDA-2019-N-5959", "Reference 32 - Factors Influencing Consumer Use of Written Drug Information - 2003 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:27:37Z", null, 0, 0, "0900006485a94a30"], ["FDA-2019-N-5959-0042", "FDA", "FDA-2019-N-5959", "Reference 39 - ER-LA Opioid Analgesics REMS - The Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy - 2014 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:29:13Z", null, 0, 0, "0900006485a94a35"], ["FDA-2019-N-5959-0040", "FDA", "FDA-2019-N-5959", "Reference 37 - Patient Information Leaflets - Patients' Comprehension of Information About Interactions and Contraindications - 2005 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:28:46Z", null, 0, 0, "0900006485a94bd6"], ["FDA-2019-N-5959-0010", "FDA", "FDA-2019-N-5959", "Reference 07 - An update on medication guides - 2017 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:01:28Z", null, 0, 0, "0900006485a8e57e"], ["FDA-2019-N-5959-0022", "FDA", "FDA-2019-N-5959", "Reference 19 - FDA - Prototype 1 Rheutopia - 2009 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:07:37Z", null, 0, 0, "0900006485a8e583"], ["FDA-2019-N-5959-0006", "FDA", "FDA-2019-N-5959", "Reference 03 - Nonadherence to antihypertensive drugs - A systematic review and meta-analysis - 2017 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T17:59:22Z", null, 0, 0, "0900006485a8e57d"], ["FDA-2019-N-5959-0014", "FDA", "FDA-2019-N-5959", "Reference 11 - Expert and Consumer Evaluation of Patient Medication Leaflets Provided in U.S. Pharmacies - 2005 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:02:26Z", null, 0, 0, "0900006485a9479f"], ["FDA-2019-N-5959-0067", "FDA", "FDA-2019-N-5959", "Reference 65 - Evergreening, patent challenges, and effective market life in pharmaceuticals RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:35:26Z", null, 0, 0, "0900006485a98d68"], ["FDA-2019-N-5959-0077", "FDA", "FDA-2019-N-5959", "Reference 75 - Table of Small Business Size Standards Matched to North American Industry Classification System Codes RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:38:27Z", null, 0, 0, "0900006485a99650"], ["FDA-2019-N-5959-0066", "FDA", "FDA-2019-N-5959", "Reference 64 - Attitudes and Beliefs About the Use of Over-the-Counter Medicines: A Dose of Reality RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:35:17Z", null, 0, 0, "0900006485a98d67"], ["FDA-2019-N-5959-0074", "FDA", "FDA-2019-N-5959", "Reference 72 - Patients' Use and Perception of Medication Information Leaflets RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:37:48Z", null, 0, 0, "0900006485a99648"], ["FDA-2019-N-5959-0004", "FDA", "FDA-2019-N-5959", "Reference 01 - Evaluation of Written Prescription Information Provided in Community Pharmacies: A Study in Eight States - 2003 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-01T21:40:43Z", null, 0, 0, "0900006485a8cc61"], ["FDA-2019-N-5959-0059", "FDA", "FDA-2019-N-5959", "Reference 57 - The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:33:25Z", null, 0, 0, "0900006485a984af"], ["FDA-2019-N-5959-0062", "FDA", "FDA-2019-N-5959", "Reference 60 - Orange Book RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:34:03Z", null, 0, 0, "0900006485a9871b"], ["FDA-2019-N-5959-0079", "FDA", "FDA-2019-N-5959", "Reference 77 - A critical review of FDA-approved Medication Guides - 2006 RE", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:38:49Z", null, 0, 0, "0900006485a9e27f"], ["FDA-2019-N-5959-0056", "FDA", "FDA-2019-N-5959", "Reference 54 - May 2020 National Occupational Employment and Wage Estimates United States RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:32:49Z", null, 0, 0, "0900006485a96b89"], ["FDA-2019-N-5959-0076", "FDA", "FDA-2019-N-5959", "Reference 74 - Do patients see, read and retain the new mandatory\nmedicines information leaflets? RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:38:14Z", null, 0, 0, "0900006485a996e2"], ["FDA-2019-N-5959-0058", "FDA", "FDA-2019-N-5959", "Reference 56 - Variations in Patients\u2019 Adherence to Medical Recommendations A Quantitative Review of 50 Years of Research RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:33:12Z", null, 0, 0, "0900006485a9858c"], ["FDA-2019-N-5959-0065", "FDA", "FDA-2019-N-5959", "Reference 63 - Effective Patent Life in Pharmaceuticals RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:34:39Z", null, 0, 0, "0900006485a98ae8"], ["FDA-2019-N-5959-0064", "FDA", "FDA-2019-N-5959", "Reference 62 - FDA 2020b - Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations to Date RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:34:27Z", null, 0, 0, "0900006485a9e27e"], ["FDA-2019-N-5959-0034", "FDA", "FDA-2019-N-5959", "Reference 31 - Preferences for Patient Medication Information: What Do Patients Want? - 2014 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:26:44Z", null, 0, 0, "0900006485a94a2f"], ["FDA-2019-N-5959-0046", "FDA", "FDA-2019-N-5959", "Reference 43 - Assessing Readability of Patient Education Materials - Current Role in Orthopaedics - 2010 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:30:01Z", null, 0, 0, "0900006485a94bd8"], ["FDA-2019-N-5959-0031", "FDA", "FDA-2019-N-5959", "Reference 28 - Making Prescription Medication Information User-Friendly: The Time Has Come - 2013 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:25:54Z", null, 0, 0, "0900006485a94958"], ["FDA-2019-N-5959-0007", "FDA", "FDA-2019-N-5959", "Reference 04 - Medication Adherence: The Elephant in the Room - 2018 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T17:59:36Z", null, 0, 0, "0900006485a94799"], ["FDA-2019-N-5959-0008", "FDA", "FDA-2019-N-5959", "Reference 05 - Economic impact of medication nonadherence\nby disease groups: a systematic review - 2018 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:00:10Z", null, 0, 0, "0900006485a9479a"], ["FDA-2019-N-5959-0027", "FDA", "FDA-2019-N-5959", "Reference 24 - Exploring the Promise of Patient Medication Information July 1, 2014 - Meeting Summary RE Medication Guides: Patient Medication\nInformation", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:09:26Z", null, 0, 0, "0900006485a94a2c"], ["FDA-2019-N-5959-0060", "FDA", "FDA-2019-N-5959", "Reference 58 - Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:33:40Z", null, 0, 0, "0900006485a97f83"], ["FDA-2019-N-5959-0071", "FDA", "FDA-2019-N-5959", "Reference 69 - Expert and Consumer Evaluation of Consumer Medication Information \u2010 2008 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:37:09Z", null, 0, 0, "0900006485a991bd"], ["FDA-2019-N-5959-0054", "FDA", "FDA-2019-N-5959", "Reference 52 - Influence of patient medication information format on comprehension and application of medication information: A randomized, controlled experiment - 2015 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:31:48Z", null, 0, 0, "0900006485a96e24"], ["FDA-2019-N-5959-0016", "FDA", "FDA-2019-N-5959", "Reference 13 - Expert and Consumer Evaluation of Consumer Medication Information \u2010 2008 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:03:06Z", null, 0, 0, "0900006485a8e580"], ["FDA-2019-N-5959-0024", "FDA", "FDA-2019-N-5959", "Reference 21 - FDA - Prototype 3 Rheutopia - 2009 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:08:27Z", null, 0, 0, "0900006485a94953"], ["FDA-2019-N-5959-0036", "FDA", "FDA-2019-N-5959", "Reference 33 - Providing Patients with Written Medication Information - 1998 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:27:52Z", null, 0, 0, "0900006485a94a31"], ["FDA-2019-N-5959-0043", "FDA", "FDA-2019-N-5959", "Reference 40 - Key Principles to Guide Development of Consumer Medicine Information - Content Analysis of Information Design Texts - 2009 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:29:25Z", null, 0, 0, "0900006485a94c30"], ["FDA-2019-N-5959-0015", "FDA", "FDA-2019-N-5959", "Reference 12 - Evaluation of Written Prescription Information Provided in Community Pharmacies, 2001 RE Medication Guides: Patient Medication\nInformation", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:02:50Z", null, 0, 0, "0900006485a8e57f"], ["FDA-2019-N-5959-0017", "FDA", "FDA-2019-N-5959", "Reference 14 - Summary of Public Hearing on FDA's Use of Medication Guides to Distribute Drug Risk Information to Patients June 12-13, 2007 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:03:23Z", null, 0, 0, "0900006485a947a0"], ["FDA-2019-N-5959-0025", "FDA", "FDA-2019-N-5959", "Reference 22 - FDA Prototype 4 Rheutopia - 2009 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:08:43Z", null, 0, 0, "0900006485a94954"], ["FDA-2019-N-5959-0026", "FDA", "FDA-2019-N-5959", "Reference 23 - FDA - Providing Effective Information to Consumers About Prescription Drug Risks and Benefits; Public Workshop Summary - September 24-25, 2009 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:09:08Z", null, 0, 0, "0900006485a8e584"], ["FDA-2019-N-5959-0009", "FDA", "FDA-2019-N-5959", "Reference 06 - Health Literacy, Processing Capacity, Illness Knowledge,\nand Actionable Memory for Medication Taking in Type 2 Diabetes: Cross-Sectional Analysis - 2021 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:01:11Z", null, 0, 0, "0900006485a9479b"], ["FDA-2019-N-5959-0013", "FDA", "FDA-2019-N-5959", "Reference 10 - FDA Public Workshop on Current Status of Useful Written Prescription Drug Information for Patient - Meeting Summary - 2000 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:02:13Z", null, 0, 0, "0900006485a9479e"], ["FDA-2019-N-5959-0019", "FDA", "FDA-2019-N-5959", "Reference 16 - National Association of Chain Drug Stores - Withdrawal of Citizen Petition Requesting FDA Action on a \"One Document Solution\" for All Pharmacy-Based Communications - 2010 - Docket FDA-2008-P-0380-0008 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T18:04:20Z", null, 0, 0, "0900006485a947a1"], ["FDA-2019-N-5959-0052", "FDA", "FDA-2019-N-5959", "Reference 50 - Valuing Time in U.S. Department of Health and Human Services Regulatory Impact Analyses: Conceptual Framework and Best Practices - 2017 RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:31:22Z", null, 0, 0, "0900006485a96e20"], ["FDA-2019-N-5959-0063", "FDA", "FDA-2019-N-5959", "Reference 61 - FDA 2020  RE Medication Guides: Patient Medication Information", "Supporting & Related Material", "Background Material", "2023-06-01T04:00:00Z", 2023, 6, null, null, "2023-06-08T19:34:15Z", null, 0, 0, "0900006485a98d63"], ["FDA-2019-N-5959-0001", "FDA", "FDA-2019-N-5959", "Medication Guides: Patient Medication Information", "Proposed Rule", "Amendment", "2023-05-31T04:00:00Z", 2023, 5, "2023-05-31T04:00:00Z", "2023-11-28T04:59:59Z", "2024-09-05T01:00:43Z", "2023-11354", 0, 0, "0900006485a9510f"]], "truncated": false, "filtered_table_rows_count": 78, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2019-N-5959", "p2": "2023"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023", "results": [{"value": "FDA", "label": "FDA", "count": 78, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2019-N-5959&posted_year=2023", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 77, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023", "results": [{"value": 2023, "label": 2023, "count": 78, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2019-N-5959&posted_year=2023&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 638.4350280277431, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}